Patient preferences and extended-release naltrexone: A new opportunity to treat opioid use disorders in Ukraine

BACKGROUND: Scaling up HIV prevention for people who inject drugs (PWID) using opioid agonist therapies (OAT) in Ukraine has been restricted by individual and structural factors. Extended-release naltrexone (XR-NTX), however, provides new opportunities for treating opioid use disorders (OUDs) in thi...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Drug Alcohol Depend
Auteurs principaux: Marcus, Ruthanne, Makarenko, Iuliia, Mazhnaya, Alyona, Zelenev, Alexei, Polonsky, Maxim, Madden, Lynn, Filippovych, Sergii, Dvoriak, Sergii, Springer, Sandra A., Altice, Frederick L.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5599372/
https://ncbi.nlm.nih.gov/pubmed/28806638
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.drugalcdep.2017.07.010
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires